Home » Topics » Regulatory

Regulatory
RSS

Avandia approved in Mexico, approval recommended in U.S.

April 23, 1999

Amoxil cleared for b.i.d. dosing in children

April 22, 1999

FDA grants priority review status to Alza' sNDA for Doxil in ovarian cancer

April 20, 1999

European Commission approves novel albumin-free treatment for hemophilia A

April 19, 1999

Furosemide prevents sound-induced seizures in rat model

April 19, 1999

FDA approves amprenavir, first new protease inhibitor in more than two years

April 19, 1999

Higher dose of Rebif approved in E.U. for multiple sclerosis

April 15, 1999

In vitro and in vivo antitumor effects of noscapine discussed at AACR meeting

April 15, 1999

FDA approves Fragmin for DVT after hip replacement surgery

April 13, 1999

SangStat's ciclosporin capsules filed for approval in U.K.

April 12, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...